Mary Schramke, Kevin Corcoran, Susan Desmond-Hellmann, Larry Kleinman, Charles Kalmbach, Theo Melas-Kyriazi, Elliot Sigal, Gary Noon, Bob Beltz, Pedro Granadillo, Andras Guttman | GenomeWeb

Mary Schramke was named acting chief executive officer for Lynx Therapeutics effective Dec. 15, the company said this week. She succeeds Kevin Corcoran who resigned as president, CEO, and director to pursue another business opportunity, the company said. Schramke previously was vice president of business development for Lynx, where she has worked since 2003.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.